CTI BIOPHARMA CORP 4
4 · CTI BIOPHARMA CORP · Filed Feb 5, 2016
Insider Transaction Report
Form 4
Plunkett Matthew
EVP, Corporate Development
Transactions
- Sale
Common Stock
2016-02-04$1.15/sh−5,000$5,750→ 604,684 total - Sale
Common Stock
2016-02-04$1.16/sh−3,000$3,465→ 601,684 total - Sale
Common Stock
2016-02-04$1.17/sh−700$819→ 600,384 total - Sale
Common Stock
2016-02-04$1.14/sh−400$456→ 609,684 total - Sale
Common Stock
2016-02-04$1.16/sh−600$696→ 601,084 total - Sale
Common Stock
2016-02-04$1.18/sh−300$353→ 600,084 total
Footnotes (1)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan.